ScholarIQanswers from OpenAlex & ORCID
Sandra Navarra
ResearcherPublications, citations & collaboration network
Sandra Navarra is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sandra Navarra have?
ScholarIQindexed works
Sandra Navarra has 185 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sandra Navarra have?
ScholarIQcitation count
Sandra Navarra has 9,348 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sandra Navarra?
ScholarIQh-index
Sandra Navarra has an h-index of 38 in OpenAlex.
What is the i10-index of Sandra Navarra?
ScholarIQi10-index
Sandra Navarra has an i10-index of 66 in OpenAlex.
What is the ORCID of Sandra Navarra?
ScholarIQorcid
The ORCID for Sandra Navarra is on the source record.
What is the OpenAlex record for Sandra Navarra?
ScholarIQopenalex
The OpenAlex for Sandra Navarra is on the source record.
What are the most-cited papers on Sandra Navarra?
ScholarIQmost cited works
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra Navarra, Renato Guzmán, A Gallacher, Stephen Hall, Roger A. Levy, Renato Jimenez, Edmund KM Li, Mathew Thomas, Ho‐Youn Kim, Manuel Gustavo Leon, C Tănăsescu, Е. Л. Насонов, Joung-Liang Lan, Lilia Pineda, Z. John Zhong, William W. Freimuth, Michelle Petri
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang‐Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard Furie, Dafna D. Gladman, Frédéric Houssiau, Luís Inês, David Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F. Morand, Gabriella Moroni, Marta Mosca, Johanna Mücke, Chetan Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José María Pego‐Reigosa, Michelle Petri, Bernardo A. Pons‐Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Kate Franklyn, Chak Sing Lau, Sandra Navarra, Worawit Louthrenoo, Aisha Lateef, Laniyati Hamijoyo, Cesarius Singgih Wahono, Shun Le Chen, Ou Jin, Susan Morton, Alberta Hoi, Molla Huq, Mandana Nikpour, Eric F. Morand
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Susan Manzi, Jorge Sánchez‐Guerrero, Joan T. Merrill, Richard Furie, Dafna D. Gladman, Sandra Navarra, Ellen M. Ginzler, David D’Cruz, Andrea Doria, Simon Cooper, Z. John Zhong, Douglas R. Hough, William W. Freimuth, Michelle Petri
Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: Prevalence, incidence, clinical features, and mortality
Rupert W. Jakes, Sang‐Cheol Bae, Worawit Louthrenoo, Chi‐Chiu Mok, Sandra Navarra, Namhee Kwon